BioSpace News Archive

Career Advice

6 Biggest Mistakes Job Seekers Make

In order to make sure that evaluation is always positive and in favor of your candidacy, avoid making these whopping mistakes when you’re on the job hunt.

June 29, 2018
·
3 min read
Business

Galapagos Plunges Following Mixed CF Trial Results and AbbVie Decision to Walk Away From Collaboration

Shares of Galapagos NV fell more than 15 percent Thursday afternoon and continued to fall in premarket trading after the Belgium-based company said AbbVie opted to walk away from its cystic fibrosis collaboration.

June 29, 2018
·
2 min read
·
Alex Keown
Business

Acceleron and Celgene Blood Disease Drug Luspatercept Hits The Mark in Phase III Trial

Acceleron Pharma plans to seek regulatory approval next year for its investigational drug luspatercept. The treatment hit its Phase III endpoints.

June 29, 2018
·
2 min read
·
Alex Keown
Business

BIO CEO Jim Greenwood Applauds SEC Amendments that Provide Regulatory Relief for Emerging Biotechs

A recent change to the definition of “smaller reporting company” by the U.S. Securities and Exchange Commission earned praise from the Biotechnology Innovation Organization.

June 29, 2018
·
2 min read
·
Alex Keown
Deals

Companies Mark Bay Area’s Eighth and Ninth Biotech IPOs

It’s been a pretty good year for biotech initial public offerings (IPOs), with two Bay Area biotechs marking numbers eight and nine for the area.

June 29, 2018
·
2 min read
·
Mark Terry
Business

Biogen Increases Ownership in Samsung Bioepis

Cambridge, Massachusetts-based Biogen exercised its option to acquire additional shares of Samsung Bioepis, a joint venture with Samsung BioLogics that was founded in 2012.

June 29, 2018
·
3 min read
·
Mark Terry
Business

Novartis to Spin off Its Alcon Eye Care Business

Switzerland-based Novartis announced it plans to spin off Alcon, its eye care division, into a separately-traded standalone company.

June 29, 2018
·
2 min read
·
Mark Terry
Drug Development

FDA Approves Dermira’s Qbrexza for Treatment of Excessive Underarm Sweating

Shares of Menlo Park, Calif.-based Dermira jumped more than 10 percent this morning after the U.S. Food and Drug Administration (FDA) approved its therapy for people who have excessive underarm sweating.

June 29, 2018
·
2 min read
·
Alex Keown
Drug Development

A Roundup of Some of This Week’s Clinical Trial Successes!

This week had a few disappointing clinical trials, as do most weeks, but it also had a number of significant successes. Here’s a look at some of the clinical trials that met their primary endpoints this week.

June 29, 2018
·
5 min read
·
Mark Terry
FDA

ACADIA Pharmaceuticals Announces FDA Approval of New Dosing Formulation and Strength for NUPLAZID® (Pimavanserin)

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced Food and Drug Administration (FDA) approval of a new capsule dose formulation and...

June 29, 2018
·
6 min read